Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP739797.RAMCxiCK7LV9f-e278-jogOll5JDVcL1TgaMkiBeHJQGI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP739797.RAMCxiCK7LV9f-e278-jogOll5JDVcL1TgaMkiBeHJQGI130_assertion type Assertion NP739797.RAMCxiCK7LV9f-e278-jogOll5JDVcL1TgaMkiBeHJQGI130_head.
- NP739797.RAMCxiCK7LV9f-e278-jogOll5JDVcL1TgaMkiBeHJQGI130_assertion description "[In addition, we found that cells with copy number enhancement of v-abl Abelson murine leukemia viral oncogene homolog 2 (ABL2) and ephrin receptor kinase and v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) (SRC) kinase family genes were exquisitely sensitive to treatment with the SRC/ABL inhibitor dasatinib, both in vitro and when it xenografted into mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP739797.RAMCxiCK7LV9f-e278-jogOll5JDVcL1TgaMkiBeHJQGI130_provenance.
- NP739797.RAMCxiCK7LV9f-e278-jogOll5JDVcL1TgaMkiBeHJQGI130_assertion evidence source_evidence_literature NP739797.RAMCxiCK7LV9f-e278-jogOll5JDVcL1TgaMkiBeHJQGI130_provenance.
- NP739797.RAMCxiCK7LV9f-e278-jogOll5JDVcL1TgaMkiBeHJQGI130_assertion SIO_000772 19451690 NP739797.RAMCxiCK7LV9f-e278-jogOll5JDVcL1TgaMkiBeHJQGI130_provenance.
- NP739797.RAMCxiCK7LV9f-e278-jogOll5JDVcL1TgaMkiBeHJQGI130_assertion wasDerivedFrom befree-2016 NP739797.RAMCxiCK7LV9f-e278-jogOll5JDVcL1TgaMkiBeHJQGI130_provenance.
- NP739797.RAMCxiCK7LV9f-e278-jogOll5JDVcL1TgaMkiBeHJQGI130_assertion wasGeneratedBy ECO_0000203 NP739797.RAMCxiCK7LV9f-e278-jogOll5JDVcL1TgaMkiBeHJQGI130_provenance.